$1.68
-0.06-3.45%
At close: -
$1.67
-0.00980-0.58%
After Hours: 7:38 PM EDT
Comments
Loading...
Esperion Therapeutics Insider Trading Activity | NASDAQ:ESPR | Benzinga
Track the latest Esperion Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Esperion Therapeutics stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Esperion Therapeutics Inc Insiders Doing?
At Esperion Therapeutics Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 19.02K shares worth $28.48K, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On January 21, 2025, Benjamin Halladay, the company's CHIEF FINANCIAL OFFICER sold 9 shares for $2.27 each.
- On February 20, 2025, Benjamin Halladay, the company's CHIEF FINANCIAL OFFICER sold 11 shares for $1.86 each.
- On January 21, 2025, Eric Warren, the company's CHIEF COMMERCIAL OFFICER sold 123 shares for $2.26 each.
Ownership Statistics for Esperion Therapeutics Inc
Shares Outstanding
197.849M
Insider Shares Owned
2.884M
Insider Percentage Owned
1.46%
Institutional Shares Held
72.048M
Institutional Percentage Held
36.4%
| Mar 19, 2025 | Benjamin Halladay | CHIEF FINANCIAL OFFICER | -3.54K | $1.48 | -$5.24K | SELL | -0.73% | 481.71K | Mar 18 | View |
| Mar 19, 2025 | Eric Warren | CHIEF COMMERCIAL OFFICER | -2.43K | $1.49 | -$3.62K | SELL | -0.65% | 370.33K | Mar 18 | View |
| Mar 19, 2025 | Sheldon L Koenig | PRESIDENT AND CEO | -13.05K | $1.50 | -$19.62K | SELL | -0.82% | 1.57M | Mar 18 | View |
| Feb 20, 2025 | Eric Warren | CHIEF COMMERCIAL OFFICER | -239.00 | $1.87 | -$446.45 | SELL | -0.15% | 159.76K | Feb 19 | View |
| Feb 20, 2025 | Benjamin Halladay | CHIEF FINANCIAL OFFICER | -11.00 | $1.86 | -$20.46 | SELL | -0.00% | 240.67K | Feb 19 | View |
| Jan 21, 2025 | Benjamin Halladay | CHIEF FINANCIAL OFFICER | -9.00 | $2.27 | -$20.39 | SELL | -0.00% | 240.68K | Jan 17 | View |
| Jan 21, 2025 | Eric Warren | CHIEF COMMERCIAL OFFICER | -123.00 | $2.26 | -$277.98 | SELL | -0.08% | 160.00K | Jan 17 | View |
| Dec 18, 2024 | Benjamin Halladay | CHIEF FINANCIAL OFFICER | -3.25K | $2.42 | -$7.87K | SELL | -1.33% | 240.69K | Dec 17 | View |
| Dec 18, 2024 | Eric Warren | CHIEF COMMERCIAL OFFICER | -2.23K | $2.43 | -$5.43K | SELL | -1.38% | 160.12K | Dec 17 | View |
| Dec 18, 2024 | Sheldon L Koenig | PRESIDENT AND CEO | -12.45K | $2.47 | -$30.69K | SELL | -1.65% | 739.82K | Dec 17 | View |
| Nov 20, 2024 | Eric Warren | CHIEF COMMERCIAL OFFICER | -197.00 | $2.17 | -$426.50 | SELL | -0.12% | 162.35K | Nov 19 | View |
| Oct 18, 2024 | Eric Warren | CHIEF COMMERCIAL OFFICER | -107.00 | $2.12 | -$226.73 | SELL | -0.07% | 162.55K | Oct 17 | View |
| Sep 18, 2024 | Sheldon L Koenig | PRESIDENT AND CEO | -14.55K | $1.80 | -$26.13K | SELL | -1.90% | 752.27K | Sep 17 | View |
| Sep 18, 2024 | Eric Warren | CHIEF COMMERCIAL OFFICER | -2.61K | $1.78 | -$4.65K | SELL | -1.58% | 162.66K | Sep 17 | View |
| Aug 20, 2024 | Eric Warren | CHIEF COMMERCIAL OFFICER | -211.00 | $1.95 | -$410.61 | SELL | -0.13% | 165.27K | Aug 19 | View |
| Jul 19, 2024 | Eric Warren | CHIEF COMMERCIAL OFFICER | -108.00 | $2.59 | -$279.40 | SELL | -0.07% | 165.48K | Jul 17 | View |
| Jul 19, 2024 | Joanne Foody | CHIEF MEDICAL OFFICER | -917.00 | $2.60 | -$2.38K | SELL | -0.33% | 272.86K | Jul 17 | View |
| Jun 20, 2024 | Joanne Foody | CHIEF MEDICAL OFFICER | -3.29K | $2.87 | -$9.42K | SELL | -1.19% | 273.78K | Jun 18 | View |
| Jun 20, 2024 | Eric Warren | CHIEF COMMERCIAL OFFICER | -2.54K | $2.86 | -$7.25K | SELL | -1.51% | 165.59K | Jun 18 | View |
| May 20, 2024 | Eric Warren | CHIEF COMMERCIAL OFFICER | -192.00 | $2.48 | -$476.74 | SELL | -0.11% | 168.13K | May 17 | View |
| Sep 21, 2023 | Eric Warren | CHIEF COMMERCIAL OFFICER | -742.00 | $1.25 | -$923.79 | SELL | -1.07% | 68.32K | Sep 20 | View |
| Aug 21, 2023 | Eric Warren | CHIEF COMMERCIAL OFFICER | -243.00 | $1.41 | -$343.60 | SELL | -0.35% | 69.06K | Aug 18 | View |
| Jul 20, 2023 | Eric Warren | CHIEF COMMERCIAL OFFICER | -106.00 | $1.58 | -$168.01 | SELL | -0.15% | 69.30K | Jul 19 | View |
| Jun 22, 2023 | Eric Warren | CHIEF COMMERCIAL OFFICER | -603.00 | $1.48 | -$894.25 | SELL | -0.86% | 69.41K | Jun 21 | View |
| May 18, 2023 | Eric Warren | CHIEF COMMERCIAL OFFICER | -219.00 | $1.62 | -$355.66 | SELL | -0.31% | 70.01K | May 17 | View |
| May 11, 2023 | MARTIN CARROLL | DIRECTOR | 31.50K | $1.55 | $48.83K | BUY | 630.00% | 36.50K | May 10 - May 11 | View |
| May 11, 2023 | STEPHEN ROCAMBOLI | DIRECTOR | 8.11K | $1.50 | $12.13K | BUY | ∞ | 8.11K | May 10 | View |
| May 10, 2023 | Sheldon L Koenig | PRESIDENT AND CEO | 20.00K | $1.26 | $25.19K | BUY | 6.83% | 312.82K | May 09 | View |
| Apr 20, 2023 | Eric Warren | CHIEF COMMERCIAL OFFICER | -115.00 | $1.28 | -$146.97 | SELL | -0.16% | 70.23K | Apr 19 | View |
| Apr 20, 2023 | Benjamin Looker | GENERAL COUNSEL | -1.29K | $1.27 | -$1.64K | SELL | -1.52% | 83.66K | Apr 19 | View |
| Apr 20, 2023 | Joanne Foody | CHIEF MEDICAL OFFICER | -938.00 | $1.27 | -$1.19K | SELL | -0.73% | 127.06K | Apr 19 | View |
| Mar 20, 2023 | Joanne Foody | CHIEF MEDICAL OFFICER | -3.81K | $1.78 | -$6.79K | SELL | -2.89% | 128.00K | Mar 17 | View |
| Mar 20, 2023 | Sheldon L Koenig | PRESIDENT AND CEO | -7.00K | $1.78 | -$12.48K | SELL | -2.33% | 292.82K | Mar 17 | View |
| Mar 20, 2023 | Eric Warren | CHIEF COMMERCIAL OFFICER | -526.00 | $1.78 | -$937.49 | SELL | -0.74% | 70.35K | Mar 17 | View |
| Mar 08, 2023 | Eric Warren | CHIEF COMMERCIAL OFFICER | -5.09K | $5.05 | -$25.73K | SELL | -9.49% | 48.57K | Mar 07 | View |
| Mar 08, 2023 | Sheldon L Koenig | PRESIDENT AND CEO | -5.44K | $5.06 | -$27.51K | SELL | -2.72% | 194.81K | Mar 07 | View |
| Mar 08, 2023 | Joanne Foody | CHIEF MEDICAL OFFICER | -3.88K | $5.07 | -$19.67K | SELL | -3.63% | 103.06K | Mar 07 | View |
| Jan 19, 2023 | Benjamin Looker | GENERAL COUNSEL | -6.35K | $7.00 | -$44.40K | SELL | -8.96% | 64.45K | Jan 18 | View |
| Jan 19, 2023 | Joanne Foody | CHIEF MEDICAL OFFICER | -1.19K | $6.99 | -$8.32K | SELL | -1.10% | 106.94K | Jan 18 | View |
| Oct 19, 2022 | Joanne Foody | CHIEF MEDICAL OFFICER | -942.00 | $7.69 | -$7.24K | SELL | -0.86% | 108.14K | Oct 18 | View |
| Oct 19, 2022 | Eric Warren | CHIEF COMMERCIAL OFFICER | -107.00 | $7.69 | -$822.83 | SELL | -0.20% | 53.66K | Oct 18 | View |
| Sep 20, 2022 | Eric Warren | CHIEF COMMERCIAL OFFICER | -255.00 | $6.92 | -$1.76K | SELL | -0.47% | 53.77K | Sep 19 | View |
| Sep 20, 2022 | Sheldon L Koenig | PRESIDENT AND CEO | -3.39K | $6.94 | -$23.55K | SELL | -1.68% | 198.26K | Sep 19 | View |
| Aug 31, 2022 | Eric Warren | CHIEF COMMERCIAL OFFICER | 1.00K | $7.46 | $7.46K | BUY | 1.89% | 54.02K | Aug 31 | View |
| Aug 18, 2022 | Eric Warren | CHIEF COMMERCIAL OFFICER | -199.00 | $6.82 | -$1.36K | SELL | -0.37% | 53.02K | Aug 17 | View |
| Aug 08, 2022 | Sheldon L Koenig | PRESIDENT AND CEO | 8.61K | $5.80 | $49.95K | BUY | 4.53% | 198.77K | Aug 05 | View |
| Jul 20, 2022 | Joanne Foody | CHIEF MEDICAL OFFICER | -3.90K | $6.55 | -$25.55K | SELL | -3.45% | 109.08K | Jul 19 | View |
| Jul 20, 2022 | Eric Warren | CHIEF COMMERCIAL OFFICER | -431.00 | $6.58 | -$2.84K | SELL | -0.80% | 53.22K | Jul 19 | View |
| Jun 21, 2022 | Sheldon L Koenig | PRESIDENT AND CEO | -4.55K | $4.99 | -$22.72K | SELL | -2.34% | 190.16K | Jun 17 | View |
| Jun 21, 2022 | Eric Warren | CHIEF COMMERCIAL OFFICER | -256.00 | $4.90 | -$1.25K | SELL | -0.47% | 53.65K | Jun 17 | View |
| Jun 03, 2022 | MARTIN CARROLL | DIRECTOR | 5.00K | $5.64 | $28.18K | BUY | ∞ | 5.00K | Jun 02 | View |
| May 18, 2022 | Eric Warren | CHIEF COMMERCIAL OFFICER | -196.00 | $5.98 | -$1.17K | SELL | -0.36% | 53.91K | May 17 | View |
| Mar 18, 2022 | Sheldon Koenig | PRESIDENT AND CEO | -571.00 | $4.58 | -$2.62K | SELL | -0.29% | 194.72K | Mar 17 | View |
| May 26, 2021 | TARGET BIOTECH VAG BIOTECH BB | 10% OWNER | 100.00K | $20.22 | $2.02M | BUY | 2.28% | 4.48M | May 24 | View |
| May 21, 2021 | TARGET BIOTECH VAG BIOTECH BB | 10% OWNER | 200.00K | $20.37 | $4.07M | BUY | 4.79% | 4.38M | May 19 | View |
| May 07, 2021 | TARGET BIOTECH VAG BIOTECH BB | 10% OWNER | 230.00K | $20.21 | $4.65M | BUY | 5.83% | 4.18M | May 05 - May 06 | View |
| Nov 04, 2020 | TARGET BIOTECH VAG BIOTECH BB | — | 200.00K | $25.31 | $5.06M | PURCHASE | 5.34% | 3.95M | Nov 03 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.